{
    "title": "114_hr2872",
    "content": "The \"Opioid Addiction Treatment Modernization Act\" aims to address the public health epidemic of opioid addiction by increasing awareness and access to treatment options, overdose reversal, and relapse prevention. The \"Opioid Addiction Treatment Modernization Act\" aims to address opioid addiction by requiring practitioners to undergo training every 2 years from specified organizations like the American Society of Addiction Medicine. The \"Opioid Addiction Treatment Modernization Act\" requires practitioners to undergo training every 2 years from specified organizations like the American Society of Addiction Medicine. The Act also emphasizes the importance of addressing opioid detoxification, appropriate clinical use of FDA-approved drugs for addiction treatment, patient assessments, individualized treatment plans, overdose reversal, relapse prevention, counseling, and other services. The \"Opioid Addiction Treatment Modernization Act\" mandates practitioner training every 2 years from approved organizations like the American Society of Addiction Medicine. It highlights the need for opioid detoxification, FDA-approved addiction treatment drugs, patient assessments, individualized treatment plans, overdose reversal, relapse prevention, counseling, and ancillary services. The Act also requires practitioners to have the capacity to provide FDA-approved drugs for opioid addiction treatment and appropriate counseling services. The Act mandates practitioner training every 2 years from approved organizations like the American Society of Addiction Medicine. It requires practitioners to have a diversion control plan to reduce the likelihood of controlled substance diversion for opioid addiction treatment. The Act also defines a qualifying physician as one licensed under State law and meeting specific conditions. The physician must have subspecialty board certification in addiction psychiatry from the American Board of Medical Specialties, addiction certification from the American Society of Addiction Medicine, and subspecialty board certification in addiction medicine from the American Osteopathic Association. They should have participated in clinical trials leading to the approval of a narcotic drug in schedule. The physician must have specific certifications and training to treat opioid addiction, including approval of a narcotic drug for treatment. They must also meet state medical licensing board requirements for providing maintenance or detoxification treatment. The physician must have specific certifications and training approved by the Secretary to demonstrate the ability to treat and manage opiate-dependent patients. The criteria set by the Secretary are effective for 3 years and can be extended for additional 3-year periods. The physician must complete 8 hours of training every 2 years for opiate-dependent patient management. Written acknowledgment from patients is required. The Opioid Addiction Treatment Modernization Act requires patients to acknowledge medication adherence, treatment options, and have an individualized treatment plan. The Secretary will update treatment guidelines within a year of the Act's enactment. The Secretary will update treatment guidelines for opiate-dependent patients in consultation with relevant authorities and professionals. Inspection authority is granted to ensure compliance with the Act. (c) Certification of Compliance.--Within 1 year of this Act's enactment, practitioners dispensing narcotic drugs for treatment must certify compliance with the Controlled Substances Act. \n(d) Reports to Congress.--The Comptroller General will review the Act's provisions every 5 years. The Act requires a review of opioid addiction treatment services in the US and a report to Congress. The report must assess compliance with the Controlled Substances Act, measures taken by the Secretary of Health and Human Services, and the integration of evidence-based treatment options. The report to Congress must assess compliance with the Controlled Substances Act and the integration of evidence-based treatment options for opioid addiction, including medication diversion and misuse."
}